Clinical trials
Recruiting Myelodysplastic Syndromes trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 2 |
| Associazione Qol-one | 1 |
| AstraZeneca | 1 |
| BeOne Medicines | 1 |
| Celgene | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| GlaxoSmithKline | 1 |
| Groupe Francophone des Myelodysplasies | 1 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 15 |
| Leukemia, Myeloid, Acute | 4 |
| Anemia | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Hematologic Diseases | 1 |
| Hematologic Neoplasms | 1 |
| Leukemia | 1 |
| Leukemia, Myelomonocytic, Chronic | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.